Will the EU Make its Better Regulation Strategy Truly Better?
The pandemic offers the chance for the European Union to expand the scope of better regulation through innovation.
Brazil’s COVID-19 Response is Caught Between Denialism and Technocratic Hubris
Self-interested and apathetic policies by its executive made Brazil one of the most infected countries in the world.
Regulatory Uncertainty Over Emergency Powers in Switzerland
Democratic process and federalism concerns raise questions about the Swiss government’s COVID-19 policies.
Regulatory Delivery Lessons From COVID-19 Responses
Amid uncertainty, countries must learn from previous inadequacies in risk-based regulation and compliance measures.
Mexico’s Untimely Fight Against Coronavirus
Mexico’s citizens and economy suffer because the President failed to invoke the only constitutional tool to fight COVID-19.
COVID-19 and Access to Medical Care in the United States
Although Congress has failed to take big steps to ensure access to COVID-19 care, states are taking small but significant steps.
President Trump’s Regulatory Process Changes Will Not Stick
The Trump Administration’s regulatory rollbacks will not have staying power among future administrations.
Undoing the Regulatory Policies of the Trump Administration
The Administration has taken an aggressive approach in using legal tools to advance its regulatory agenda.
A Fuller Picture of the Trump Administration’s Regulatory Agenda
President Trump’s deregulatory agenda may have lasting effects beyond the term of his presidency.
Old Norms and New Challenges in Spain’s Response to COVID-19
Executive and legislative branches of Spain’s government wield debatable legal authority in times of crisis.
The Trump Administration’s Pandemic Response Is Structured to Fail
Poor organizational choices have hampered the government’s management of COVID-19.
OIRA and the Future of Cost-Benefit Analysis
The Trump Administration’s dismissiveness toward regulatory analysis reveals a need for institutional reform.